The U.S. Food and Drug Administration (FDA) green-lit Janssen’s Stelara for the treatment of adult patients with moderately to severely active ulcerative colitis after clinical trials demonstrated the drug helped patients achieve “clinical remission.”
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,